ClinicalTrials.gg
Drug

Pancrelipase clinical trials

Also written Creon, Zenpep, Pancreatin and SA-001.

studies test it
44
open now
3
in phase 3
11
first study started
1999

How each study uses Pancrelipase is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Pancrelipase studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
9 Dec 1996 · COTAZYM · BLA 020580 (FDA, Drugs@FDA; in a combination)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Pancrelipase
16
EUR-1008 (APT-1008)
4
SA001 Low dose
2
SA001 Mid dose
2
SA001 High dose
2

Brand

Creon
15
Zenpep
6
Pertzye
3

Development codes

SA-001
2
Creon36™
1
MS-16
1

Other names

Pancreatin
4

Studies by the year they started

44 studies that test it; most in 2008 (6)

Studies that test Pancrelipase, by start year
YearStudies
19991
20001
20031
20041
20051
20062
20074
20086
20091
20103
20122
20132
20142
20151
20163
20171
20181
20191
20204
20211
20222
20241
20251
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
4
Phase 2
9
Phase 3
11
Phase 4
15
No phase
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 26 · Other 18

Forest Laboratories (6) · Abbott (5) · AbbVie (4) · Abbott Products (3) · Digestive Care, Inc. (3) · Samjin Pharmaceutical Co., Ltd. (2) · Solvay Pharmaceuticals (2) · Memorial Sloan Kettering Cancer Center (1)

Often tested with

Tested in the same studies.

Bifidobacterium longum subsp. infantis (1) · Nitazoxanide (1) · Ensure Plus (1) · Bicarbonates (1) · Esomeprazole (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3

Studies that test Pancrelipase.

Studies

Open first, then newest update. How each study uses Pancrelipase is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 44

See all 44 studies that test Pancrelipase →

Given beside what is tested · 1 — Pancrelipase is usual care or a partner of the new treatment
As the comparator · 4 — what is tested is compared with Pancrelipase

Codes

What other systems call Pancrelipase · ClinicalTrials.gg INT008771

  • MeSH (NLM) D020799PancrelipaseConfirmed ClinicalTrials.gov, Wikidata
  • UNII (FDA) FQ3DRG0N5KPANCRELIPASEConfirmed FDA, Wikidata
  • RxNorm 235379Confirmed FDA, Wikidata
  • Wikidata Q7130425pancrelipaseConfirmed FDA, Wikidata
  • NCI Thesaurus C29345PancrelipaseOne source FDA
  • DrugBank DB00085One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.